Jcovden

adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S) · Janssen-Cilag International NV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Jcovden, covering 2025-09-01 to 2025-09-01. Get the full timeline:

Most recent: EMA Withdrawn: Jcovden (previously COVID-19 Vaccine Janssen) (adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)) — Janssen-Cilag International NV

See pricing